NCT02883335Recruiting
Lorraine Registry of Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 8 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6000 (estimated)
- First submitted
- 19 Aug 2016
- Start date
- May 2003
- Primary completion date
- Jan 2030
- Lead sponsor
- Central Hospital, Nancy, France
- Diseases
- Multiple sclerosis
- NCT number
- NCT02883335
What you commit to
- Study type: Observational
- Planned participants: 6000
- From May 2003 to the primary completion date, Jan 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refusal to be registered
Who the study is looking for
- Having a confirmed multiple sclerosis diagnosis
- Living in Lorraine (French region)
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy Coordinator of this site? Confirm its status | Nancy | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.